Zymergen Inc
NASDAQ:ZY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Zymergen Inc
Cash & Cash Equivalents
Zymergen Inc
Cash & Cash Equivalents Peer Comparison
DOW
OLN
VVV
WLK
CBT
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
Z
|
Zymergen Inc
NASDAQ:ZY
|
Cash & Cash Equivalents
$386.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dow Inc
NYSE:DOW
|
Cash & Cash Equivalents
$3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Olin Corp
NYSE:OLN
|
Cash & Cash Equivalents
$150.9m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-5%
|
|
|
Valvoline Inc
NYSE:VVV
|
Cash & Cash Equivalents
$494.5m
|
CAGR 3-Years
26%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Westlake Corp
NYSE:WLK
|
Cash & Cash Equivalents
$3.1B
|
CAGR 3-Years
31%
|
CAGR 5-Years
48%
|
CAGR 10-Years
19%
|
|
|
Cabot Corp
NYSE:CBT
|
Cash & Cash Equivalents
$206m
|
CAGR 3-Years
12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
See Also
What is Zymergen Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
386.1m
USD
Based on the financial report for Dec 31, 2021, Zymergen Inc's Cash & Cash Equivalents amounts to 386.1m USD.
What is Zymergen Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 1Y
84%
Over the last year, the Cash & Cash Equivalents growth was 84%.
You don't have any saved screeners yet
